KMT2D c.10126G>C ;(p.V3376L)

Variant ID: 12-49431013-C-G

NM_003482.3(KMT2D):c.10126G>C;(p.V3376L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Integrative molecular characterization of Chinese prostate cancer specimens.

Asian Journal Of Andrology
Lv, Shi-Dong SD; Wang, Hong-Yi HY; Yu, Xin-Pei XP; Zhai, Qi-Liang QL; Wu, Yao-Bin YB; Wei, Qiang Q; Huang, Wen-Hua WH
Publication Date: 2020

Variant appearance in text: KMT2D: V3376L
PubMed Link: 31134918
Variant Present in the following documents:
  • AJA-22-162.pdf
  • AJA-22-162_Suppl1.pdf
View BVdb publication page



Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.

Oncogene
Lv, Shidong S; Ji, Liyan L; Chen, Bin B; Liu, Shuqiang S; Lei, Chengyong C; Liu, Xi X; Qi, Xiaoxiao X; Wang, Ying Y; Lai-Han Leung, Elaine E; Wang, Hongyi H; Zhang, Lin L; Yu, Xiaoming X; Liu, Zhongqiu Z; Wei, Qiang Q; Lu, Linlin L
Publication Date: 2018-03

Variant appearance in text: KMT2D: V3376L
PubMed Link: 29269867
Variant Present in the following documents:
  • Main text
  • 41388_2017_Article_26.pdf
View BVdb publication page